Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

Clinical trial NCT02260687 · COMPLETED

Trial details

NCT number: NCT02260687
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Choroidal Neovascularization

Start date: 2014-12-05
Primary completion: 2018-04-02
Enrollment: 353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.